Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.
Rasmussen MIS, Hansen ML, Pellicer A, Hyttel-Sørensen S, Ergenekon E, Szczapa T, Hagmann C, Naulaers G, Mintzer J, Fumagalli M, Dimitriou G, Dempsey E, Tkaczyk J, Fredly S, Heuchan AM, Pichler G, Fuchs H, Nesargi S, Hahn GH, Piris-Borregas S, Širc J, Alsina-Casanova M, Stocker M, Ozkan H, Sarafidis K, Kraus NJ, Karen T, Rzepecka-Weglarz B, Oguz SS, Thewissen L, Arruza L, Memisoglu AC, Del Rio Florentino R, Baserga M, Maton P, Schneider J, de Las Cuevas MI, Hedegaard SS, Zafra P, Bender L, Farquharson S, Ochoda-Mazur A, Lecart C, El-Khuffash A, Chathasaigh CN, Miletin J, Papathoma E, Vesoulis Z, Serrao F; SafeBoosC-III Follow-Up Writing Group for the SafeBoosC-III Follow-Up Collaborator Group; Cornette L, Yasa B, Klamer A, Barcos-Munoz F, Boetti T, Cetinkaya M, Montasser M, Hatzidaki E, Bokiniec R, Marciniak S, Chalak L, Rao SA, Sadowska-Krawczenko I, Serrano-Viñuales I, Krolak-Olejnik B, Plomgaard AM, Hansen BM, Olsen MH, Gluud C, Jakobsen JC, Greisen G.
Rasmussen MIS, et al.
JAMA Pediatr. 2026 Apr 20:e261066. doi: 10.1001/jamapediatrics.2026.1066. Online ahead of print.
JAMA Pediatr. 2026.
PMID: 42008246
Free PMC article.